Home/Filings/4/0001213900-19-019413
4//SEC Filing

Kaplan Myron 4

Accession 0001213900-19-019413

CIK 0001410098other

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 5:14 PM ET

Size

11.1 KB

Accession

0001213900-19-019413

Insider Transaction Report

Form 4
Period: 2019-09-30
Kaplan Myron
Director
Transactions
  • Purchase

    Common Stock

    2019-09-30$6.81/sh+5,000$34,050109,734 total
Holdings
  • Stock Option (Right to Buy Common Stock)

    Exercise: $8.30Exp: 2029-01-10Common Stock (15,000 underlying)
    15,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $2.85Exp: 2028-02-16Common Stock (8,000 underlying)
    8,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $11.20Exp: 2027-02-21Common Stock (8,000 underlying)
    8,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $21.40Exp: 2026-04-28Common Stock (10,000 underlying)
    10,000
Footnotes (5)
  • [F1]Represents the weighted average purchase price of the shares purchased ranging from a low of $6.74 to a high of $6.85 per share.
  • [F2]These options were granted on 01/10/2019. The options vest monthly with 100% vesting on the one-year anniversary of the date of grant, subject to continued service on the board.
  • [F3]These options were granted on 2/16/2018. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
  • [F4]These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
  • [F5]These options were granted on 4/28/2016. These options shall vest as follows: 1/3 on 4/28/2016, 1/3 on 4/28/2017, and 1/3 on 4/28/2018.

Issuer

CorMedix Inc.

CIK 0001410098

Entity typeother

Related Parties

1
  • filerCIK 0001672645

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 5:14 PM ET
Size
11.1 KB